ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 141 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 2.67 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $7,000 | +75.0% | 360 | +20.0% | 0.00% | +100.0% |
| Q2 2019 | $4,000 | 0.0% | 300 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $4,000 | 0.0% | 300 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $4,000 | -33.3% | 300 | -16.7% | 0.00% | -33.3% |
| Q3 2018 | $6,000 | 0.0% | 360 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $6,000 | +20.0% | 360 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $5,000 | +25.0% | 360 | 0.0% | 0.00% | +50.0% |
| Q4 2017 | $4,000 | – | 360 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 229,895 | $7,593,000 | 6.73% |
| Foresite Capital Management II, LLC | 419,997 | $13,873,000 | 4.65% |
| Cormorant Asset Management, LP | 757,475 | $25,019,000 | 2.99% |
| NEXTHERA CAPITAL LP | 60,000 | $1,982,000 | 2.81% |
| SENZAR ASSET MANAGEMENT, LLC | 557,170 | $18,403,325,000 | 2.05% |
| Parametrica Management Ltd | 9,360 | $309,000 | 2.04% |
| Partner Investment Management, L.P. | 36,756 | $1,214,000 | 1.99% |
| PFM Health Sciences, LP | 1,890,030 | $62,428,000 | 1.90% |
| PYRRHO CAPITAL MANAGEMENT, LP | 63,000 | $2,081,000 | 1.40% |
| BB BIOTECH AG | 1,510,150 | $49,880,000 | 1.40% |